-+ 0.00%
-+ 0.00%
-+ 0.00%
Why Scholar Rock Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Share
Listen to the news

Shares of Scholar Rock Holding Corp (NASDAQ:SRRK) rose sharply in pre-market trading after the company announced the FDA approval of ISEMBYLD (apitegromab-mstn), the first and only muscle-targeted treatment for children and adults with Spinal Muscular Atrophy (SMA).

Scholar Rock Holding shares jumped 11.9% to $62.00 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

  • Scinai Immunotherapeutics Ltd – ADR (NASDAQ:SCNI) gained 86.9% to $3.10 in pre-market trading
  • Intercont (Cayman) Ltd (NASDAQ:NCT) gained 48.2% to $0.44 in pre-market trading after adding over 2% on Friday.
  • Rum Group Inc (NASDAQ:RUM) rose 23% to $8.82 in pre-market trading. The Information reported Sunday that Anthropic signed a $13.7 billion six-year compute deal with Trump-linked Rum Group.
  • Volato Group Inc (NYSE:SOAR) gained 21.8% to $0.23 in pre-market trading after falling 2% on Friday.
  • Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) rose 19.3% to $9.69 in pre-market trading after the company announced it will host a conference call webcast on September 14 to discuss topline data for CANYON-1.
  • VS Media Holdings Ltd (NASDAQ:VSME) rose 18.7% to $1.27  in pre-market trading after gaining 16% on Friday.
  • Lianhe Sowell International Group Ltd (NASDAQ:LHSW) rose 17.7% to $0.57 in pre-market trading after dipping around 26% on Friday.
  • Telix Pharmaceuticals (NASDAQ:TLX) gained 7.2% to $12.10 in pre-market trading after declining around 4% on Friday.
  • John Wiley & Sons Inc (NYSE:WLY) rose 6.8% to $50.22 in pre-market trading.

Losers

  • Picocela Inc – ADR (NASDAQ:PCLA) tumbled 22.9% to $7.81 in pre-market trading after gaining 4% on Friday.
  • Aardvark Therapeutics Inc (NASDAQ:AARD) fell 21.3% to $4.03 in pre-market trading after gaining 2% on Friday.
  • Cellectis SA (NASDAQ:CLLS) fell 19.4% to $2.50 in pre-market trading. The company’s board approved a strategic transformation to become an in vivo gene editing company focused on developing long-lasting treatments for chronic diseases.
  • XORTX Therapeutics Inc (NASDAQ:XRTX) fell 14.7% to $2.00 in pre-market trading after gaining 10% on Friday. XORTX Therapeutics, last week, announced the launch of production of drug material and tablet manufacturing to support its XRx-026 program for the treatment of gout.
  • MKDWELL Tech Inc (NASDAQ:MKDW) declined 13.5% to $6.71 in pre-market trading. MKDWELL Tech entered into a $100 million at-the-market offering agreement.
  • Biodexa Pharmaceuticals PLC-ADR (NASDAQ:BDRX) fell 14.5% to $1.11 in pre-market trading after the company announced interim results for the six months ended June 30, 2026.
  • Olema Pharmaceuticals Inc (NASDAQ:OLMA) fell 12.6% to $8.93 in pre-market trading after declining 4% on Friday.
  • 3 E Network Technology Group Ltd (NASDAQ:MASK) fell 11.4% to $1.09 in pre-market trading.
  • Surgepays Inc (NASDAQ:SURG) fell 10.4% to $0.16 in pre-market trading. The company last week announced the sale of its ClearLine apps engagement platform to GPO Plus for $27.5 million.
  • Cheetah Net Supply Chain Service Inc (NASDAQ:CTNT) fell 9.5% to $1.05 in pre-market trading after dropping 8% on Friday.

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending